AR

Anandakumar Rini Shalini Jeevitha

Active Director Designated Partner DIN 10811400
DIN 10811400 First appointment Oct 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Anandakumar Rini Shalini Jeevitha

Data last updated:

Anandakumar Rini Shalini Jeevitha is a Designated Partner at Trimedica Therapeutics Llp (since 2024).

DIN 10811400
Primary Designation Designated Partner
First Appointment 17 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Oct 20242024Active

Board colleagues of Anandakumar Rini Shalini Jeevitha

NameDINCompanyDesignation
Ramkishan Rao Annamaneni10811399Trimedica Therapeutics LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Trimedica Therapeutics Llp
Premium access

Shareholding and investment profile for Anandakumar Rini Shalini Jeevitha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anandakumar Rini Shalini Jeevitha

Anandakumar Rini Shalini Jeevitha currently holds 1 directorship: Trimedica Therapeutics Llp (Designated Partner, since 17 Oct 2024).

Anandakumar Rini Shalini Jeevitha was first appointed on 17 Oct 2024 as Designated Partner at Trimedica Therapeutics Llp.

The current boards of Anandakumar Rini Shalini Jeevitha's companies include Ramkishan Rao Annamaneni (Trimedica Therapeutics Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available